The EU's drug regulator approved use of the COVID-19 vaccine from U.S.-based Novavax in people aged 18 and older. Data from two large studies showed the vaccine has an efficacy of around 90%, the European Medicines Agency said
Data from two large studies showed the vaccine has an efficacy of around 90%, the European Medicines Agency said, adding there was currently limited data on its efficacy against some variants of concern, including Omicron.
Member states have ordered around 27 million doses for the first quarter, enough to inoculate about 13.5 million people, the Commission said. "May this authorisation offer a strong encouragement to everyone who has not yet been vaccinated or boosted, that now is the time to do so," said the head of the bloc's executive Commission, Ursula von der Leyen, in a statement.
The regulatory process in the EU has taken longer than expected too. The EMA started a real-time rolling review of the data in February.Novavax and the EU reached a preliminary deal in December 2020 for the supply of the vaccine, but due to regulatory and production issues the final contract was only signed in August.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
EU set to back Novavax Covid vaccineThe EU's drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Lire la suite »
Novavax’s Covid-19 Vaccine Recommended for Use in EUNovavax vaccine was recommended for use by the European drug regulator, a major step toward its clearance for use in the European Union
Lire la suite »
Sen. Warren tests positive for Covid-19Democratic Sen. Elizabeth Warren has tested positive for coronavirus, according to a tweet from her official account.
Lire la suite »
NYC Promises More Covid-19 Testing Sites After Hours-Long WaitsIn November there were 54 testing sites in the city—as of Tuesday there will be 30.
Lire la suite »
Omicron may sideline two leading drugs against COVID-19The rapidly-spreading omicron variant may soon leave U.S. doctors without two of the standard treatments they’ve used to fight COVID-19.
Lire la suite »